Embedded Files
Blood clots with COVID-19 have most often been seen in people who’ve been hospitalized with the disease. A study of 184 people in the ICU for severe COVID-19 found that 31 percent of these individuals experienced complications related to blood clots.
COVID-19 complications from blood clots can happen across all ages. A small study looked at 14 people with COVID-19 who had experienced a stroke due to a blood clot. The study found that 42 percent of participants were under age 55 and had no existing risk factors for stroke.
Although the exact mechanism is unclear, COVID-19 appears to cause increased activation of cells that are important in initiating the clotting process. This may lead to an increased risk of blood clots.
Turmeric is a spice that gives curry dishes a yellow color, and it’s long been used as a folk medicine. According to a 2012 study, one of its main active ingredients, curcumin, acts as an anticoagulant.
It works to inhibit coagulation cascade components, or clotting factors, to prevent clots from forming.
References:Kim, D. C., Ku, S. K., & Bae, J. S. (2012). Anticoagulant activities of curcumin and its derivative. BMB reports, 45(4), 221-226.
Shah, B. H., Nawaz, Z., Pertani, S. A., Roomi, A., Mahmood, H., Saeed, S. A., & Gilani, A. H. (1999). Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor-and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochemical pharmacology, 58(7), 1167-1172.
Shah, B. H., Nawaz, Z., Pertani, S. A., Roomi, A., Mahmood, H., Saeed, S. A., & Gilani, A. H. (1999). Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor-and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochemical pharmacology, 58(7), 1167-1172.
Page updated
Google Sites
Report abuse